Experienced in Medulloblastoma

Dr. Joseph C. Landolfi

Neurology
JFK New Jersey Neuroscience Institute
65 James Street, 
Edison, NJ 
Experienced in Medulloblastoma
JFK New Jersey Neuroscience Institute
65 James Street, 
Edison, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joseph Landolfi is a Neurologist in Edison, New Jersey. Dr. Landolfi is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Glioma, Gliomatosis Cerebri, Glioblastoma, and Astrocytoma.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
UMDNJ-School Of Osteopathic Medicine
Residency
Rutgers New Jersey Medical School
Specialties
Neurology
Licenses
Psychiatry & Neurology in NJ
Board Certifications
American Board Of Psychiatry And Neurology
Fellowships
Memorial Sloan-Kettering Cancer Center
Hospital Affiliations
Jfk University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

JFK New Jersey Neuroscience Institute
65 James Street, Edison, NJ 8820.
Other Locations
JFK New Jersey Neuroscience Institute
2100 Corlies Avenue, Suite 16, Neptune, NJ 7753.

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
A Phase II Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab-rwlc (Libtayo®) in Subjects With Recurrent or Progressive Glioblastoma
A Phase II Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab-rwlc (Libtayo®) in Subjects With Recurrent or Progressive Glioblastoma
Enrollment Status: Terminated
Publish Date: April 18, 2025
Intervention Type: Drug, Biological
Study Drugs: Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc
Study Phase: Phase 2
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

9 Total Publications

NS-HGlio: A generalizable and repeatable HGG segmentation and volumetric measurement AI algorithm for the longitudinal MRI assessment to inform RANO in trials and clinics.
NS-HGlio: A generalizable and repeatable HGG segmentation and volumetric measurement AI algorithm for the longitudinal MRI assessment to inform RANO in trials and clinics.
Journal: Neuro-oncology advances
Published: January 23, 2023
Similar Doctors
Distinguished in Medulloblastoma
Dr. Eli L. Diamond
Neurology
Distinguished in Medulloblastoma
Dr. Eli L. Diamond
Neurology

Memorial Neurology Group

160 E 53rd St, 
New York, NY 
 (24.3 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eli Diamond is a Neurologist in New York, New York. Dr. Diamond is rated as an Elite provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Erdheim-Chester Disease, Glioblastoma, Astrocytoma, Brain Tumor, and Awake Craniotomy.

Jon Glass
Distinguished in Medulloblastoma
Dr. Jon Glass
Neurology | Oncology
Distinguished in Medulloblastoma
Dr. Jon Glass
Neurology | Oncology

Voorhees Specialty Care

333 Laurel Oak Road, 
Voorhees, NJ 
 (59.5 miles away)
215-955-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jon Glass is an Oncologist in Voorhees, New Jersey. Dr. Glass is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Gliosarcoma, Glioblastoma, and Neuroepithelioma. Dr. Glass is currently accepting new patients.

Advanced in Medulloblastoma
Dr. Amy A. Pruitt
Neurology
Advanced in Medulloblastoma
Dr. Amy A. Pruitt
Neurology

Penn Neuroscience Center - Neurology

3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
 (61.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Amy Pruitt is a Neurologist in Philadelphia, Pennsylvania. Dr. Pruitt is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Medulloblastoma, and Brain Tumor. Dr. Pruitt is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Landolfi's expertise for a condition
ConditionClose
    View All 14 Distinguished Conditions
    View All 7 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile